Clearance of Helicobacter pylori infection through immunization: The site of T cell activation contributes to vaccine efficacy

Vaccine

Volumn 22, Issue 7, 2004, Pages 888-897

  Blanchard, Thomas G ^a,b   Eisenberg, Julia C ^b   Matsumoto, Yuko ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Helicobacter pylori; Immunization; Vaccine efficacy

Indexed keywords

BACTERIAL VACCINE; CD4 ANTIGEN; CHOLERA TOXIN; ENTEROTOXIN; ESCHERICHIA COLI ENTEROTOXIN; FREUND ADJUVANT; HELICOBACTER PYLORI VACCINE; INTERLEUKIN 10; OXIDOREDUCTASE;

ABDOMINAL CRAMP; BACTERIAL INFECTION; CELL ACTIVATION; CLINICAL TRIAL; CONFERENCE PAPER; DIARRHEA; DOWN REGULATION; DRUG EFFICACY; EXPERIMENTAL MODEL; GASTRITIS; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOREGULATION; INFLAMMATION; LYMPH NODE; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROVOCATION TEST; STOMACH; T LYMPHOCYTE ACTIVATION;

EID: 0842324634     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.11.035     Document Type: Conference Paper

References (71)

1. Marshall B.J. The 1995 Albert Lasker Medical Research Award. H. pylori. The etiologic agent for peptic ulcer. J. Am. Med. Assoc. 274(13):1995;1064-1066.
2. Marshall B.J., Warren J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1(8390):1984;1311-1315.
3. Marshall B.J., Armstrong J.A., McGechie D.B., Glancy R.J. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med. J. Aust. 142(8):1985;436-439.
4. Morris A., Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am. J. Gastroenterol. 82(3):1987;192-199.
5. NIH Consensus Conference. H. pylori in peptic ulcer disease. J Am Med Assoc 1994;272:65-9.
6. World Health Organization. Schistosomes, liver flukes and H. pylori. Lyon: International Agency for Research on Cancer; 1994. p. 177-241.
7. Dooley C.P., Cohen H., Fitzgibbons P.L., Bauer M., Appleman M.D., Perez-Perez G.I.et al. Prevalence of H. pylori infection and histologic gastritis in asymptomatic persons. New Engl. J. Med. 321:1989;1562-1566.
8. Warren J.R. Gastric pathology associated with H. pylori. Gastrenterol. Clin. North Am. 29(3):2000;705-751.
9. Rathbone B.J., Wyatt J.I., Worsley B.W., Shires S.E., Trejdosiewicz L.K., Heatley R.V.et al. Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut. 27:1986;642-647.
10. Wyatt J.I., Rathbone B.J., Heatley R.V. Local immune response to gastric Campylobacter in non-ulcer dyspepsia. J. Clin. Pathol. 39(8):1986;863-870.
11. Blanchard T.G., Nedrud J.G., Czinn S.J. Local and systemic antibody responses in humans with H. pylori infection. Can. J. Gastroenterol. 13(7):1999;591-594.
12. Blanchard T.G., Nedrud J.G., Reardon E.S., Czinn S.J. Qualitative and quantitative analysis of the local and systemic antibody response in mice and humans with Helicobacter immunity and infection. J. Infect. Dis. 179(3):1999;725-728.
13. Karttunen R., Andersson G., Poikonen K., Kosunen T.U., Karttunen T., Juutinen K.et al. H. pylori induces lymphocyte activation in peripheral blood cultures. Clin. Exp. Immunol. 82:1990;485-488.
14. Karttunen R. Blood lymphocyte proliferation, cytokine secretion and appearance of T cells with activation surface markers in cultures with H. pylori. Comparison of the responses of subjects with and without antibodies to H. pylori. Clin. Exp. Immunol. 83(3):1991;396-400.
15. Karttunen R., Karttunen T., Ekre H.P., MacDonald T.T. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in H. pylori positive and negative gastritis. Gut. 36(3):1995;341-345.
16. Sharma S.A., Miller G.G., Perez-Perez G.I., Gupta R.S., Blaser M.J. Humoral and cellular immune recognition of H. pylori proteins are not concordant. Clin. Exp. Immunol. 97(1):1994;126-132.
17. Fan X.J., Chua A., Shahi C.N., McDevitt J., Keeling P.W., Kelleher D. Gastric T lymphocyte responses to H. pylori in patients with H. pylori colonisation. Gut. 35(10):1994;1379-1384.
18. Di Tommaso A., Xiang Z., Bugnoli M., Pileri P., Figura N., Bayeli P.F.et al. H. pylori-specific CD4+ T-cell clones from peripheral blood and gastric biopsies. Infect. Immun. 63:1995;1102-1106.
19. D'Elios M.M., Manghetti M., De Carli M., Costa F., Baldari C.T., Burroni D.et al. T helper 1 effector cells specific for H. pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 158:1997;962-967.
20. Lindholm C., Quiding-Jarbrink M., Lonroth H., Hamlet A., Svennerholm A.M. Local cytokine response in H. pylori-infected subjects. Infect. Immun. 66(12):1998;5964-5971.
21. Sommer F., Faller G., Konturek P., Kirchner T., Hahn E.G., Zeus J.et al. Antrum- and corpus mucosa-infiltrating CD4(+) lymphocytes in H. pylori gastritis display a Th1 phenotype. Infect. Immun. 66:1998;5543-5546.
22. Bamford K.B., Fan X., Crowe S.E., Leary J.F., Gourley W.K., Luthra G.K. et al. Lymphocytes in the human gastric mucosa during H. pylori have a T helper cell 1 phenotype. Gastroenterology. 114:1998;482-492.
23. Lee A., Fox J.G., Otto G., Murphy J. A small animal model of human H. pylori active chronic gastritis. Gastroenterology. 99(5):1990;1315-1323.
24. Czinn S.J., Cai A., Nedrud J.G. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine. 11:1993;637-642.
25. Chen M., Lee A., Hazell S. Immunisation against gastric Helicobacter infection in a mouse/Helicobacter felis model. Lancet. 339:1992;1120-1121.
26. Nedrud J.G., Liang X.P., Hague N., Lamm M.E. Combined oral/nasal immunization protects mice from Sendai virus infection. J. Immunol. 139(10):1987;3484-3492.
27. Czinn S.J., Nedrud J.G. Oral immunization against H. pylori. Infect. Immun. 59(7):1991;2359-2363.
28. Michetti P., Corthesy-Theulaz I., Davin C., Haas R., Vaney A.C., Heitz M.et al. Immunization of BALB/c mice against Helicobacter felis infection with H. pylori urease. Gastroenterology. 107:1994;1002-1011.
29. Ferrero R.L., Thiberge J.-M., Huerre M., Labigne A. Recombinant antigens prepared from the urease subunits of Helicobacter spp: evidence of protection in a mouse model of gastric infection. Infect. Immun. 62:1994;4981-4989.
30. Ferrero R.L., Thiberge J.M., Kansau I., Wuscher N., Huerre M., Labigne A. The GroES homolog of H. pylori confers protective immunity against mucosal infection in mice. Proc. Natl. Acad. Sci. U.S.A. 92(14):1995;6499-6503.
31. Corthesy-Theulaz I., Porta N., Glauser M., Saraga E., Vaney A.C., De Carli M.et al. Oral immunization with H. pylori urease B subunit as a treatment against Helicobacter infection in mice. Gastroenterology. 109:1995;115-121.
32. Doidge C., Crust I., Lee A., Buck F., Hazell S., Manne U. Therapeutic immunisation against Helicobacter infection. Lancet. 343(8902):1994;914-915.
33. Cuenca R., Blanchard T.G., Czinn S.J., Nedrud J.G., Monath T.P., Lee C.K.et al. Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets. Gastroenterology. 110:1996;1770-1775.
34. Garhart C.A., Redline R.W., Nedrud J.G., Czinn S.J. Clearance of H. pylori infection and resolution of postimmunization gastritis in a kinetic study of prophylactically immunized mice. Infect. Immun. 70(7):2002;3529-3538.
35. Ermak T.H., Ding R., Ekstein B., Hill J., Myers G.A., Lee C.K.et al. Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria. Gastroenterology. 113:1997;1118-1128.
36. Marchetti M., Arico B., Burroni D., Figura N., Rappuoli R., Ghiara P. Development of a mouse model of H. pylori infection that mimics human disease. Science. 267(5204):1995;1655-1658.
37. Ghiara P., Rossi M., Marchetti M., Di Tommaso A., Vindigni C., Ciampolini F.et al. Therapeutic intragastric vaccination against H. pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection. Infect. Immun. 65:1997;4996-5002.
38. Michetti P., Kreiss C., Kotloff K.L., Porta N., Blanco J.-L., Bachmann D.et al. Oral immunization with urease and E. coli heat-labile enterotoxin is safe and immunogenic in H. pylori-infected adults. Gastroenterology. 116:1999;804-812.
39. Marchetti M., Rossi M., Giannelli V., Giuliani M.M., Pizza M., Censini S.et al. Protection against H. pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant. Vaccine. 16:1998;33-37.
40. Kleanthous H., Myers G.A., Georgakopoulos K.M., Tibbitts T.J., Ingrassia J.W., Gray H.L.et al. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against H. pylori infection. Infect. Immun. 66:1998;2879-2886.
41. Garhart C.A., Heinzel F.P., Czinn S.J., Nedrud J.G. Vaccine-induced reduction of H. pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent. Infect. Immun. 71(2):2003;910-921.
42. Fujihashi K., Koga T., van Ginkel F.W., Hagiwara Y., McGhee J.R. A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants. Vaccine. 20(19-20):2002;2431-2438.
43. Gottwein J.M., Blanchard T.G., Targoni O.S., Eisenberg J.C., Zagorski B.M., Redline R.W.et al. Protective anti-Helicobacter immunity is induced with aluminum hydroxide or complete Freund's adjuvant by systemic immunization. J. Infect. Dis. 184:2001;308-314.
44. Eisenberg J.C., Czinn S.J., Garhart C.A., Redline R.W., Bartholomae W.C., Gottwein J.M.et al. Protective efficacy of anti-H. pylori immunity following systemic immunization of neonatal mice. Infect. Immun. 71:2003;1820-1827.
45. Guy B., Hessler C., Fourage S., Haensler J., Vialon-Lafay E., Rokbi B.et al. Systemic immunization with urease protects mice against H. pylori infection. Vaccine. 16:1998;850-856.
46. Weltzin R., Guy B., Thomas W.D. Jr., Giannasca P.J., Monath T.P. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric H. pylori infection. Infect. Immun. 68(5):2000;2775-2782.
47. Blanchard T.G., Czinn S.J., Redline R.W., Sigmund N., Harriman G., Nedrud J.G. Antibody-independent protective mucosal immunity to gastric helicobacter infection in mice. Cell Immunol. 191(1):1999;74-80.
48. Ermak T.H., Giannasca P.J., Nichols R., Myers G.A., Nedrud J., Weltzin R.et al. Immunization of mice with urease vaccine affords protection against H. pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J. Exp. Med. 188:1998;2277-2288.
49. Sutton P., Wilson J., Kosaka T., Wolowczuk I., Lee A. Therapeutic immunization against H. pylori infection in the absence of antibodies. Immunol. Cell. Biol. 78:2000;28-30.
50. Pappo J., Torrey D., Castriotta L., Savinainen A., Kabok Z., Ibraghimov A. H. pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions. Infect. Immun. 67(1):1999;337-341.
51. Lucas B., Bumann D., Walduck A., Koesling J., Develioglu L., Meyer T.F. et al. Adoptive transfer of CD4+ T cells specific for subunit A of H. pylori urease reduces H. pylori stomach colonization in mice in the absence of interleukin-4 (IL-4)/IL-13 receptor signaling. Infect. Immun. 69:2001;1714-1721.
52. Akhiani A.A., Pappo J., Kabok Z., Schon K., Gao W., Franzen L.E.et al. Protection against H. pylori infection following immunization is IL-12-dependent and mediated by Th1 cells. J. Immunol. 169:2002;6977-6984.
53. Sawai N., Kita M., Kodama T., Tanahashi T., Yamaoka Y., Tagawa Y.et al. Role of gamma interferon in H. pylori-induced gastric inflammatory responses in a mouse model. Infect. Immun. 67:1999;279-285.
54. Garhart C.A., Nedrud J.G., Heinzel F.P., Sigmund N.E., Czinn S.J. Vaccine-induced protection against H. pylori in mice lacking both antibodies and interleukin-4. Infect. Immun. 71(6):2003;3628-3633.
55. Blanchard T.G., Yu F., Hsieh C.L., Redline R.W. Severe inflammation and reduced bacteria load in murine helicobacter infection caused by lack of phagocyte oxidase activity. J. Infect. Dis. 187(10):2003;1609-1615.
56. Mohammadi M., Czinn S., Redline R., Nedrud J. Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J. Immunol. 156(12):1996;4729-4738.
57. Fox J.G., Beck P., Dangler C.A., Whary M.T., Wang T.C., Shi H.N.et al. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat. Med. 6:2000;536-542.
58. Smythies L.E., Waites K.B., Lindsey J.R., Harris P.R., Ghiara P., Smith P.D. H. pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-γ, gene-deficient mice. J. Immunol. 165(2):2000;1022- 1029.
59. Goto T., Nishizono A., Fujioka T., Ikewaki J., Mifune K., Nasu M. Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against H. pylori infection after oral vaccination of mice. Infect. Immun. 67(5):1999;2531-2539.
60. Lundgren A., Suri-Payer E., Enarsson K., Svennerholm A.M., Lundin B.S. H. pylori-specific CD4+ CD25 high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect. Immun. 71(4):2003;1755-1762.
61. Raghavan S., Fredriksson M., Svennerholm A.M., Holmgren J., Suri-Payer E. Absence of CD4+ CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in H. pylori-infected mice. Clin. Exp. Immunol. 132(3):2003;393-400.
62. Groux H., O'Garra A., Bigler M., Rouleau M., Antonenko S., de Vries J.E.et al. A CD4+ T-cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature. 389:1997;737-742.
63. Muminova Z., Saparov A., Oliver J.R., Thomas J.S., Weaver C.T. Antigen-specific T cell clones derived from the lamina propria of TCR transgenic mice have a Tr1-like cytokine phenotype. FASEB J. 13:1999;A942.
64. Chen W., Shu D., Chadwick V.S. H. pylori infection: mechanism of colonization and functional dyspepsia: reduced colonization of gastric mucosa by H. pylori in mice deficient in interleukin-10. J. Gastroenterol. Hepatol. 16(4):2001;377-383.
65. Pollack J.D., Williams D.A., Gifford M.A.C., Li L.L., Du X., Fisherman J.et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet. 9:1995;202-209.
66. Pappo J., Thomas W.D. Jr., Kabok Z., Taylor N.S., Murphy J.C., Fox J.G. Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis. Infect. Immun. 63(4):1995;1246-1252.
67. Khoo U.Y., Proctor I.E., Macpherson A.J.S. CD4+ T cell down-regulation in human intestinal mucosa: evidence for intestinal tolerance to lumenal bacterial antigens. J. Immunol. 158:1997;3626-3634.
68. Chen Y., Kuchroo V.K., Inobe J.-I., Hafler D.A., Weiner H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 265:1994;1237-1240.
69. Powrie F. T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity. 3:1995;171-174.
70. Powrie F., Leach M.W., Mauze S., Caddle L.B., Coffman R.L. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice. Int. Immunol. 5:1993;1461-1471.
71. Blaser M.J. Hypothesis: the changing relationships of H. pylori and humans: implications for health and disease. J. Infect. Dis. 179:1999;1523-1530.